CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Jaundice, Obstructive

Jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.

Drugs by status

Phase 3 trials (5)

  • ringer's lactate
  • nicotinamide
  • sodium succinate
  • methionine
  • inosine

Phase 2 trials (4)

  • ursodeoxycholic acid
  • cow milk
  • neostigmine
  • raceanisodamine

Other trials (2)

  • porfimer
  • methylene blue

Organizations

Organization Involved with Phase 3 Indications (9)

  • Polysan, Ltd.
  • Petrov Research Institute of Oncology
  • BioEq
  • St. Petersburg Mechnikov State Medical Academy
  • Irkutsk Regional Clinical Hospital
  • Avicenna Medical Center
  • Regional Clinical oncologic center, Omsk region
  • State Budgetary Health Care Institution "City Hospital № 26"
  • Leningrad Regional Clinical Hospital

Organization Involved with Phase 2 Indications (5)

  • University Clinical Centre of Kosova
  • University of Florida
  • University of Zagreb
  • University of Kosovo
  • People's Liberation Army of China

Organization Involved with Other Experimental Indications (1)

  • Sungkyunkwan University

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.